6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid has been researched along with Arteriosclerosis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Elstner, EF; Kögl, C; Schneider, W | 1 |
| Fiorillo, C; Nassi, P; Nediani, C; Oliviero, C; Pacini, A; Rizzuti, G | 1 |
2 other study(ies) available for 6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid and Arteriosclerosis
| Article | Year |
|---|---|
The influence of magnesium-pyridoxal-5'-phosphate-glutamate in comparison with probucol, alpha-tocopherol and trolox on copper-induced oxidation of human low density lipoprotein in vitro.
Topics: Arteriosclerosis; Chromans; Copper; Fatty Acids; Glutamine; Humans; In Vitro Techniques; Lipoproteins, LDL; Oxidation-Reduction; Probucol; Pyridoxal Phosphate; Vitamin E | 1994 |
Oxidative stress and antioxidant defenses in renal patients receiving regular haemodialysis.
Topics: Antioxidants; Arteriosclerosis; Chromans; Fatty Acids, Unsaturated; Female; Humans; Kidney Failure, Chronic; Lipid Peroxidation; Male; Malondialdehyde; Middle Aged; Oxidative Stress; Reactive Oxygen Species; Renal Dialysis; Risk Factors; Triglycerides | 1998 |